Harrow, Inc. Increase (Decrease) in Contract with Customer, Liability
Harrow, Inc. (HROW) reported Increase (Decrease) in Contract with Customer, Liability of $13.24 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2025-05-08
- Harrow, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $13.24M, a 35694.59% increase year-over-year.
- Harrow, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-09-30 was -$111.00K, a 628.57% decline year-over-year.
- Harrow, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-06-30 was $136.00K, a 109.23% increase year-over-year.
- Harrow, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-03-31 was $37.00K.
- Harrow, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$38.00K, a 139.18% decline from fiscal 2022.
- Harrow, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was $97.00K.
- Harrow, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was -$50.00K, a 655.56% decline from fiscal 2020.
- Harrow, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $9.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-03-31 | $13.24M 10-Q · filed 2025-05-08 | |||
| 2024-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $25.00K derived: sum of 2 quarters · filed 2024-11-14 | $62.00K 10-Q · filed 2024-11-14 | -$16.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $173.00K 10-Q · filed 2024-08-07 | $95.00K derived: sum of 3 quarters · filed 2024-08-07 | $116.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $37.00K 10-Q · filed 2024-05-13 | -$41.00K derived: sum of 2 quarters · filed 2024-05-13 | -$20.00K derived: sum of 3 quarters · filed 2024-11-14 | $45.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$57.00K derived: sum of 2 quarters · filed 2024-11-14 | $8.00K derived: sum of 3 quarters · filed 2024-11-14 | -$38.00K 10-K · filed 2024-03-19 |
| 2023-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $86.00K derived: sum of 2 quarters · filed 2024-11-14 | $40.00K 10-Q · filed 2024-11-14 | $38.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $19.00K 10-Q · filed 2024-08-07 | $17.00K derived: sum of 3 quarters · filed 2024-08-07 | $49.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$46.00K 10-Q · filed 2024-05-13 | -$48.00K derived: sum of 2 quarters · filed 2024-05-13 | -$16.00K derived: sum of 3 quarters · filed 2024-05-13 | $44.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $30.00K derived: sum of 2 quarters · filed 2024-03-19 | $90.00K derived: sum of 3 quarters · filed 2024-03-19 | $97.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $92.00K derived: sum of 2 quarters · filed 2023-11-13 | $99.00K 10-Q · filed 2023-11-13 | $112.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $67.00K 10-Q · filed 2023-08-09 | $80.00K derived: sum of 3 quarters · filed 2023-08-09 | $27.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-11 | $20.00K derived: sum of 2 quarters · filed 2023-05-11 | -$33.00K derived: sum of 3 quarters · filed 2023-05-11 | $20.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$40.00K derived: sum of 2 quarters · filed 2023-03-23 | $13.00K derived: sum of 3 quarters · filed 2023-03-23 | -$50.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$63.00K 10-Q · filed 2022-11-14 | -$60.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$10.00K 10-Q · filed 2022-08-09 | -$7.00K derived: sum of 3 quarters · filed 2022-08-09 | $3.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$63.00K 10-Q · filed 2022-05-05 | -$60.00K derived: sum of 2 quarters · filed 2022-05-05 | -$50.00K derived: sum of 3 quarters · filed 2022-05-05 | -$57.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $13.00K derived: sum of 2 quarters · filed 2022-03-10 | $6.00K derived: sum of 3 quarters · filed 2022-03-10 | $9.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.00K derived: sum of 2 quarters · filed 2021-11-09 | $6.00K 10-Q · filed 2021-11-09 | $15.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$4.00K 10-Q · filed 2021-08-10 | $5.00K derived: sum of 3 quarters · filed 2021-08-10 | -$171.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $3.00K 10-Q · filed 2021-05-11 | $12.00K derived: sum of 2 quarters · filed 2021-05-11 | -$164.00K derived: sum of 3 quarters · filed 2021-05-11 | -$299.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$167.00K derived: sum of 2 quarters · filed 2021-03-08 | -$302.00K derived: sum of 3 quarters · filed 2021-03-08 | -$62.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | -$176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$311.00K derived: sum of 2 quarters · filed 2020-11-09 | -$71.00K 10-Q · filed 2020-11-09 | -$50.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $105.00K 10-Q · filed 2020-08-10 | $126.00K derived: sum of 3 quarters · filed 2020-08-10 | $190.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $240.00K 10-Q · filed 2020-05-11 | $261.00K derived: sum of 2 quarters · filed 2020-05-11 | $325.00K derived: sum of 3 quarters · filed 2020-05-11 | $286.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $85.00K derived: sum of 2 quarters · filed 2020-03-13 | $46.00K derived: sum of 3 quarters · filed 2020-03-13 | $90.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $25.00K derived: sum of 2 quarters · filed 2019-11-13 | $69.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $5.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $44.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$62.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |